The Latest Breaking News on Pharma

Bushfire emergency measures allowed repeat medication to be prescribed without prescription. But those powers have been scaled back.

While national efforts to eliminate hepatitis C have faced setbacks because of increased drug use, the impact of COVID-19 and insurance complications, there’s a bright spot: Some states are now making it easier for patients to treat the disease.

NYC and Cambridge-based Empyrean Neuroscience Inc. is a new genetic engineering company developing neuroactive compounds for neuropsychiatric and neurological disorders launching with a $22 million Series A financing.

The California Cannabis Industry Association (CCIA), a trade group representing hundreds of companies participating in the United States’ largest regulated cannabis market, has released a white paper entitled “Pandora’s Box: The Dangers of a National, Unregulated, Hemp-Derived Intoxicating Cannabinoid Market.&

Kampala (AFP) - The death toll from an Ebola epidemic declared last month in Uganda has climbed to 44, the World Health Organization said on Wednesday.

An FDA advisory panel voted 14-1 on Wednesday to recommend that the agency withdraw its approval of the drug Makena, saying the treatment does not appear to reduce the risk of preterm birth.

Amid the macroeconomic issues and rampant volatility in the market, investor sentiment toward biotech stocks is declining. Many companies in this space are planning layoffs to reduce expenses. Amid the grim backdrop, we think investors should drop fundamentally weak biotech stocks Ginkgo Bioworks Holdings (DNA) and Immunic (IMUX) from their…

Novavax won Food and Drug Administration for its Covid booster on Wednesday, but NVAX stock dipped slightly in response.

There are fears of a "twindemic" of Covid and flu this winter